PROK Archived Articles
ProKidney Corp. (NASDAQ:PROK): Pioneering a First-in-Class Cell Therapy for Chronic Kidney Disease
Published on March 16, 2025
ProKidney Corp (PROK): A Pioneer in Chronic Kidney Disease Treatment Pushing the Boundaries of Cell Therapy
Published on November 19, 2024
ProKidney Corp. (NASDAQ:PROK): A Transformative Cell Therapy Platform with Promising Potential
Published on September 24, 2024